BioNTech (Germany)

BioNTech (Germany)

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (Germany), Germany, covering academic research published from 2003 to 2024. Read More.


Open Access Percentage

70%


Total
Publications

570


Total Open
Publications

397


Total
Citations

36K


Open Access
Percentage

70%


Total
Publications

570


Total Open
Publications

397


Total
Citations

36K

Wikipedia

Website

download

Breakdown

22% 39% 6% 33%

Publisher Open

22%

Both

39%

Other Platform Open

6%

Closed

33%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

49%OA Journal

OA Journal 49%

155

Hybrid 27%

84

No Guarantees 24%

74

Other Platform Open

Domain 86%

199

Institution 19%

44

Other Internet 12%

28

Preprint 4%

10

Public 1%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
198
DOI
Other Internet
28
Europe PMC
Domain
11
DANS - Data Archiving and Networked Services
Institution
7
Research Square
Preprint
6
ZB MED - Informationszentrum Lebenswissenschaften
Institution
5
Université de Lausanne - SERVAL
Institution
3
unideb.hu OAI-PMH Repository
Institution
3
Preprints
Preprint
3
Imperial College London - Spiral
Institution
3
1 / 4

Data updated 18 August 2025

Share

Share

Share